Edition:
United Kingdom

Viveve Medical Inc (VIVE.OQ)

VIVE.OQ on NASDAQ Stock Exchange Capital Market

2.52USD
13 Jul 2018
Change (% chg)

-- (--)
Prev Close
$2.52
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
117,019
52-wk High
$7.57
52-wk Low
$1.60

Latest Key Developments (Source: Significant Developments)

Viveve Submits VIVEVE II Clinical Study Safety Data To FDA
Tuesday, 3 Jul 2018 

July 3 (Reuters) - Viveve Medical Inc ::VIVEVE SUBMITS VIVEVE II CLINICAL STUDY 30-DAY PATIENT SAFETY DATA TO FDA.VIVEVE MEDICAL INC - NO SERIOUS ADVERSE EVENTS REPORTED IN SUBMISSION OF VIVEVE II CLINICAL STUDY 30-DAY PATIENT SAFETY DATA TO FDA.VIVEVE MEDICAL - FINAL STUDY RESULTS COULD SUPPORT A MARKETING APPLICATION FOR EXPANDED U.S. INDICATION FOR IMPROVEMENT OF SEXUAL FUNCTION IN WOMEN.  Full Article

Viveve Appoints Scott Durbin As Chief Executive Officer
Thursday, 10 May 2018 

Viveve Medical Inc ::VIVEVE APPOINTS SCOTT DURBIN AS CHIEF EXECUTIVE OFFICER.VIVEVE MEDICAL INC - DURBIN'S APPOINTMENT FOLLOWS PATRICIA SCHELLER'S DECISION TO STEP DOWN FROM HER POSITION AS CHIEF EXECUTIVE OFFICER.VIVEVE MEDICAL INC - DURBIN WILL ALSO JOIN BOARD OF DIRECTORS.VIVEVE MEDICAL INC - SCHELLER WILL REMAIN ON VIVEVE BOARD OF DIRECTORS.VIVEVE MEDICAL - DURBIN'S APPOINTMENT FOLLOWS PATRICIA SCHELLER'S DECISION TO STEP DOWN FROM HER POSITION AS CEO.  Full Article

Viveve Announces Preliminary 2017 Fourth Quarter Results
Thursday, 4 Jan 2018 

Jan 4 (Reuters) - Viveve Medical Inc ::VIVEVE ANNOUNCES PRELIMINARY 2017 FOURTH QUARTER AND YEAR-END FINANCIAL RESULTS AND PROVIDES 2018 REVENUE GUIDANCE.SEES FY 2018 REVENUE $22 MILLION TO $24 MILLION.SEES FY 2017 REVENUE $15.3 MILLION.FY2017 REVENUE VIEW $15.5 MILLION -- THOMSON REUTERS I/B/E/S.FY2018 REVENUE VIEW $23.6 MILLION -- THOMSON REUTERS I/B/E/S.  Full Article

Viveve Medical Inc files for mixed shelf of up to $50 million
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Viveve Medical Inc :Viveve Medical Inc files for mixed shelf of up to $50 million .  Full Article

Viveve reports Q3 loss per share $0.50
Wednesday, 8 Nov 2017 

Nov 8 (Reuters) - Viveve Medical Inc :Viveve announces third quarter 2017 financial results.Q3 loss per share $0.50.Q3 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S.Q3 revenue $4.1 million versus i/b/e/s view $3.7 million.  Full Article

Viveve releases preliminary Q3 2017 financial results
Wednesday, 18 Oct 2017 

Oct 18 (Reuters) - Viveve Medical Inc :Viveve releases preliminary third quarter 2017 financial results.Viveve Medical- sees Q3 revenue from sale of 60 Viveve systems, about 2,700 disposable treatment tips, ancillary consumables to be about $4.1 million​‍​.  Full Article

Viveve gets regulatory nod to market Viveve System in Mexico
Tuesday, 17 Oct 2017 

Oct 17 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Mexico.Viveve Medical - received approval from Mexican regulatory authority, COFEPRIS, to market Viveve System in Mexico for treatment of vaginal introitus​.Viveve Medical Inc - working to submit IDE to FDA to conduct pivotal study on use of Viveve System for improvement in sexual function in women​.  Full Article

Viveve announces regulatory approval for Viveve System in Taiwan
Tuesday, 10 Oct 2017 

Oct 10 (Reuters) - Viveve Medical Inc :Viveve announces regulatory approval for Viveve System in Taiwan.Viveve Medical - got approval to market Viveve System from Taiwanese FDA for use in general surgical procedures for electrocoagulation,hemostasis​.Viveve - In process of submitting investigational device exemption to U.S FDA to conduct study on use of device for improvement in sexual function in women​.  Full Article

Viveve secures $30 million debt financing with CRG
Tuesday, 23 May 2017 

May 23 (Reuters) - Viveve Medical Inc :Viveve secures $30 million debt financing with crg.Viveve medical inc - new credit facility consists of $20 million to be drawn at closing.Viveve medical inc - new credit facility alsoconsists of ability to access additional funding of up to an aggregate of $10 million.Viveve medical inc - term of loan is six years with first four years being interest only.  Full Article

Viveve announces pricing of public offering of shares of common stock
Friday, 17 Mar 2017 

Viveve Medical Inc : Viveve announces pricing of public offering of shares of common stock .Says public offering of 7.50 million common shares priced at $4.00per share.  Full Article

BRIEF-Viveve Says FDA Signs Off On Clinical Study

* VIVEVE ANNOUNCES FDA APPROVAL OF IDE TO CONDUCT VIVEVE II CLINICAL STUDY